พบ "Medical Diagnostic Equipments"ทั้งหมด 204 ผลลัพธ์
เรียงลำดับตาม
ความเกี่ยวข้อง

18th HTAsiaLink Newsletter: The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions.(2011)

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions Download at http://www.resource-allocation.com/content/9/1/8 Sitaporn Youngkong1,2*, Noor Tromp1† and Dereck Chitama1,3† * Corresponding author: Sitaporn Youngkong [email protected]

Health Related Quality of Life among Patient with Tuberculosis and HIV in Thailand. (2012)

Health Related Quality of Life among Patient with Tuberculosis and HIV in Thailand. Wanitchaya Kittikraisak , Pritaporn Kingkaew, Yot Teerawattananon, Jomkwan Yothasamut, Supalert Natesuwan, Weerawat Manosuthi, Virasakdi Chongsuvivatwong, Sara J. Whitehead Abstract Introduction Health util

Evidence to Inform Decision Makers in Thailand: A Cost Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis. (2012)

Evidence to Inform Decision Makers in Thailand: A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis. Pritaporn Kingkaew, BPharm, MSccorrespondenceemail, Usawadee Maleewong, BPharm, PhD, Chardpraorn Ngarmukos, MD, Yot Teerawattananon, MD, PhD Abst

Involvement of consumers in health technology assessment activities by INAHTA agencies (2013)

Involvement of consumers in health technology assessment activities by INAHTA agencies. David Haileya1, Sophie Werköa2, Rugayah Bakria3, Alun Camerona4, Britta Göhlena5, Susan Mylesa6, Jasmine Pwua7 and Jomkwan Yothasamuta8 For the INAHTA Working Group on Impact of HTA a1 University of Wollong

A cost – utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. (2013)

A cost–utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Adun Mohara1, Román Pérez Velasco1, Naiyana Praditsitthikorn1,2, Yingyos Avihingsanon3 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP),

Health Care Coverage Decision Making in Low- and Middle-Income Countries: Experiences from 25 Coverage Schemes (2014)

Hialy Gutierrez, MPH,1,2 Ashwini Shewade, MS, MSc,1 Minghan Dai, MPH,1 Pedro Mendoza-Arana, MD, MSc,3 Octavio Go´mez-Dante´s, MD, MPH,4 Nishant Jain, PhD,5 Irma Khonelidze, MPA,6 Juliet Nabyonga-Orem, MD, MSc,7 Karima Saleh, PhD,8 Yot Teerawattananon, MD, PhD,9 Sania Nishtar, SI, PhD,10 and John Hor

How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings? (2016)

Yot Teerawattananon, Alia Luz* , Songyot Pilasant, Suteenoot Tangsathitkulchai, Sarocha Chootipongchaivat, Nattha Tritasavit, Inthira Yamabhai and Sripen Tantivess Abstract Background: It is very challenging for resource-limited settings to introduce universal health coverage (UHC), particular

Coverage Decisions and the Court: A Public Health Perspective on Glucosamine Reimbursement in Thailand (2016)

Sripen Tantivess & Viroj Tangcharoensathien Abstract Thailand achieves universal health coverage through the introduction of 3 benefit schemes: the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme, and Universal Coverage Scheme. The primary benefit package of these sche

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)

Background Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li
10 / หน้า